Gayatri

Gayatri is the Analyst for IP News, specializing in complex litigation and policy developments in intellectual property ecosystem. Expertise and Background Gayatri holds a Master’s degree. Her professional experience spans focusing on the intersection of pharmaceutical patents, trademark jurisprudence, and digital rights enforcement. Focus Areas: Patents Act 1970, Trademark Act 1999, Delhi High Court litigation analysis, and the enforcement of statutory standards like Section 3(d) (efficacy) and the Bolar exemption. Analytical Approach: Gayatri's reporting is distinguished by its meticulous breakdown of court orders, transforming complex legal language into actionable insights for the corporate, scientific, and legal communities. She uses the latest case law and judicial trends to provide readers with accurate, forward-looking analysis of the Indian legal landscape.

Delhi High Court Rejects Toyota’s Plea for Interim Relief in Patent Infringement Case Against Indian Company

by

New Delhi, July 5, 2025 — The Delhi High Court has refused to grant interim relief to global automobile major Toyota in a patent infringement lawsuit it filed against an Indian company. The Court’s order signals a firm approach to evaluating intellectual property claims, especially in complex technology-related cases.

🔎 The Lawsuit

Toyota, a leading Japanese car manufacturer, approached the Delhi High Court claiming that an Indian firm had unlawfully used its patented automotive technology. Though details of the patent involved were not made public, Toyota argued that the Indian company’s products infringed upon its exclusive intellectual property rights.

The company sought a court-ordered injunction, hoping to immediately stop the Indian firm from using or selling the allegedly infringing products in the Indian market. Toyota emphasized the importance of protecting its technological innovations and preventing damage to its brand and business.

⚖️ Court’s Stand

The case was heard by Justice Anish Dayal, who declined Toyota’s request for interim relief. The Court ruled that holding a patent alone is not enough to justify an injunction at the preliminary stage.

Justice Dayal observed that patent disputes often involve technical complexities and require deeper investigation. He stated that a mere claim of infringement cannot result in a blanket order against the defendant without careful judicial scrutiny.

The Court emphasized the importance of considering all sides. It weighed the “balance of convenience” and the potential hardship that an injunction could cause to the Indian company. The judge ruled that an immediate halt to operations could unfairly affect the Indian firm before the matter is fully adjudicated.

🧩 Legal Significance

This decision reinforces the judiciary’s cautious approach in IP matters. It highlights that patent holders — even large multinational corporations — must present strong, clear evidence before expecting urgent court action.

The Court’s refusal does not end the matter. Instead, it means the case will now move forward through the regular judicial process. Both parties will have the opportunity to present their arguments and technical evidence in detail.

🏭 Implications for the Indian Company

The Indian firm, whose identity remains undisclosed in initial reports, has gained temporary relief through the Court’s decision. It will be allowed to continue its business activities for now. This ruling offers reassurance to Indian businesses that patent enforcement actions will be tested thoroughly and fairly, especially when initiated by foreign giants.

🌐 Industry Context

Toyota is known for vigorously defending its intellectual property globally. As India’s automotive sector continues to grow, patent disputes between local manufacturers and global players are becoming more common. This case is an example of the challenges multinational corporations face when navigating India’s legal landscape.

The ruling also underlines the importance of strong legal documentation and evidence when initiating IP litigation in India. Courts are unlikely to grant early-stage relief without thoroughly understanding the technical merits of the case.

📌 Conclusion

The Delhi High Court’s decision to reject Toyota’s plea for interim relief underscores its commitment to due process in patent cases. While the matter is still under legal review, the Court has sent a clear message — all parties, regardless of their size or origin, must meet the same standards of proof before expecting judicial intervention.

⚠️ Disclaimer:

This article is based on publicly available reports and is for informational purposes only. It does not constitute legal advice. For accurate legal interpretation, readers should refer to official court documents or consult legal professionals.

Garmin’s New Patent Hints at Wearable Tech for Monitoring Hydration and Hematocrit Levels

by

Garmin, the global leader in wearable fitness technology, is pushing the boundaries of health tracking. A newly published patent reveals that the company is working on a novel method to monitor hydration levels and hematocrit concentration using optical sensors. This breakthrough could redefine how smartwatches assess real-time health.

Optical Tech Behind the Innovation

The patent, granted in the U.S., details a system based on pulse spectroscopy. This is an advanced version of photoplethysmography (PPG), a light-based method already used in many smartwatches for heart rate and oxygen tracking.

The system uses near-infrared light wavelengths—specifically around 850 nm and 1000 nm. These wavelengths penetrate the skin and allow for a more accurate read on blood volume and tissue characteristics. Garmin’s system measures pulsatile volume changes in blood vessels compared to surrounding tissue. These variations are then analyzed to determine hydration and hematocrit levels.

What is Hematocrit?

Hematocrit means the % of RBC in the blood. It plays a critical role in oxygen delivery. Abnormal levels can signal dehydration, anemia, or overtraining. Until now, measuring hematocrit typically required invasive lab tests. Garmin’s wearable method could make this data accessible to everyday users and athletes alike.

Hydration Tracking Reimagined

Unlike current hydration reminders based on time or estimated sweat loss, Garmin’s patented method could track actual hydration changes in the body. This can be a game-changer for endurance athletes, fitness enthusiasts, and even those with medical conditions sensitive to fluid levels.

Users could receive alerts like:
“Your hydration is 4% below optimal,”
rather than generic prompts like “Time to drink water.”

Potential Applications

Endurance training: Prevent dehydration and monitor red blood cell health.

Recovery tracking: Detect overtraining early through hematocrit changes.

Health management: Monitor real-time hydration during illness or travel.

General wellness: Track water needs more scientifically than manual logging.

Timeline for Release?

While the technology is promising, a patent does not confirm an imminent release. Garmin will need to conduct clinical trials, ensure regulatory approvals, and optimize sensor calibration for various skin types. Experts suggest it could take 12–24 months before these features debut in consumer devices.

If integrated, it will likely appear first in Garmin’s premium models like the Fenix, Forerunner, or Epix lines.

Disclaimer:

This article is based on publicly available information from Garmin’s recent patent filing. The features discussed are conceptual and may not reflect final products. Garmin has not officially announced any product with this capability as of now.

IG Drones Secures India’s First Patent for Indigenous Defence Drone Simulator

by

In a landmark achievement for India’s defence and aerospace technology sector, IG Drones has been granted a patent for its indigenously developed defence drone simulator — the first of its kind in the country. This breakthrough not only showcases the nation’s growing technological self-reliance but also positions IG Drones at the forefront of next-generation military training systems.

The simulator, which gained national attention when it was showcased by Prime Minister Narendra Modi during the Defence Expo 2022, has been entirely conceptualized, designed, and developed within India. It aims to provide high-fidelity, immersive training to personnel across the Indian Army, Navy, Air Force, and paramilitary forces, enabling them to conduct drone operations in realistic, high-risk simulated environments.

Speaking on the achievement, IG Drones founder and CEO, Bodhisattwa Sanghapriya, described the patent as a “proud declaration of India’s technological resurgence.” He credited the success to the innovation-friendly environment under Prime Minister Modi’s leadership and reiterated the company’s commitment to advancing the country’s defence capabilities through indigenous technology.

“Our simulator is a cutting-edge system that will transform the way defence forces are trained in drone operations,” Sanghapriya stated. “By simulating real combat scenarios in a safe and controlled environment, we are drastically reducing operational risks and costs, while also enhancing mission readiness.”

Advanced Features Driving Technological Excellence
The state-of-the-art simulator is packed with sophisticated features, including:

AI-Powered Systems: Adaptive artificial intelligence allows for dynamic scenario generation and realistic enemy behaviour, helping trainees respond to unpredictable situations.

Physics-Based Simulation Engine: Real-world physics are accurately replicated, giving users an authentic flying and combat experience.

Real-Time Terrain Modelling: The system includes live terrain rendering to mimic India’s diverse geographic conditions — from mountainous regions to coastal zones and urban warfare settings.

Training in GPS-Denied Environments: The simulator supports operations in GPS-denied zones, critical for modern-day electronic warfare scenarios.

Multi-Drone Mission Capability: Personnel can train for complex operations involving coordination between multiple unmanned aerial vehicles (UAVs), enhancing collaborative tactics and situational awareness.

Strategic Implications for Indian Defence
The development is expected to significantly reduce India’s reliance on foreign training systems and simulators, aligning with the country’s ‘Aatmanirbhar Bharat’ (self-reliant India) initiative. By offering a secure and cost-effective alternative to imported solutions, IG Drones’ simulator represents a major leap in indigenous defence manufacturing and training infrastructure.

Moreover, the patent solidifies IG Drones’ position as a key contributor to India’s military modernization efforts. With drone warfare becoming increasingly vital in contemporary defence strategy, such indigenous tools will play a crucial role in preparing Indian forces for future conflicts.

A Milestone for ‘Make in India’ in Defence
This patent marks not just a technological innovation but a broader policy success under India’s defence indigenization efforts. The government’s push for local innovation and production in the sector appears to be bearing fruit, with startups like IG Drones leading the charge.

With this achievement, India joins a small group of nations capable of independently developing and patenting advanced defence simulation technologies. The success of this simulator is expected to open up new avenues for exports and global collaborations in the defence tech domain.

Disclaimer

The information provided in this article is based on publicly available sources and official statements released by IG Drones. While every effort has been made to ensure the accuracy and completeness of the content, the publisher does not take responsibility for any discrepancies or subsequent changes to the facts as presented. This article is intended for informational purposes only and does not constitute legal, technical, or investment advice. Any views or quotes attributed to individuals are presented as per their public statements and do not reflect the opinions of the publisher.

Bombay High Court Rules on Bollywood Song Copyright Infringement: Legacy Music Rights Cover Digital Platforms

by

In a significant judgment concerning copyright ownership of iconic Bollywood songs, the Bombay High Court has dismissed a lawsuit filed by the daughter of late filmmaker O.P. Ralhan against FMCG giant Adani Wilmar Ltd and others. The plaintiff, Rupali P. Shah, had challenged the continued commercial use of musical works from seven Hindi films produced between 1963 and 1983, alleging copyright infringement.

Background of the Case

Rupali Shah approached the court claiming ownership of music rights to the films Phool Aur Patthar, Talash, Hulchul, Bandhe Haath, Paapi, Spy in Rome, and Return of Mr. Superman. She alleged that the original rights assigned decades ago only included limited usage formats—such as gramophone records—and did not authorize distribution through digital platforms like streaming services or online videos.

The defendants, including Adani Wilmar and other music companies, argued that the rights had been validly and permanently assigned in earlier agreements. They contended that the assignment covered “any and every means whatsoever,” thereby including present and future technologies not known at the time of execution.

Court’s Verdict

Justice Manish Pitale of the Bombay High Court ruled in favor of the defendants, interpreting the assignment clauses broadly. The court held that even though the original agreements referred specifically to gramophone records and similar physical formats, the wording also clearly permitted exploitation through “any and every means whatsoever”—a phrase the court deemed expansive enough to include evolving formats like digital and online media.

The judge emphasized that the purpose of such contracts is to ensure commercial use of creative works across technological advancements unless explicitly restricted.

Legal Reasoning

Justice Pitale noted that contractual clauses must be interpreted in light of the parties’ intent and the technological foresight available at the time. The court stated that the assignment’s language was unambiguous and allowed for modern-day commercial use. Therefore, no infringement occurred, and the rights holders’ licenses remain valid in perpetuity.

Significance of the Ruling

This verdict reaffirms that older copyright agreements with broadly worded clauses can still be enforceable in the digital era. The decision provides legal clarity for companies using vintage content, as long as their rights are clearly defined in contracts. It also serves as a precedent for similar copyright infringement disputes involving legacy works and new-age media formats.

Disclaimer

This article is based on publicly available court records and news published on LiveLaw.in. It has been rewritten for informational and educational purposes only and does not constitute legal advice. All names, references, and legal interpretations are drawn from verified sources at the time of publication. For professional legal advice, please consult a qualified attorney.

Delhi Court Orders ₹290 Crore Security in Patent Battle

by

In a landmark development in India’s intellectual property (IP) litigation landscape, the Delhi High Court has directed South Korean telecom equipment maker Ace Technologies Corp. to deposit ₹290 crore as interim security in an ongoing patent infringement suit filed by Canadian company Communication Components Antenna Inc. (CCA).

The single-judge bench of Justice Saurabh Banerjee issued the order citing the need to secure the plaintiff’s interests in the absence of any mutual legal enforcement treaty between India and South Korea.

Background of the Dispute

The legal battle stems from allegations by CCA that Ace Technologies unlawfully manufactured and supplied advanced beamforming antenna systems to Reliance Jio Infocomm Ltd, violating CCA’s Indian patent covering next-generation multi-beam antenna technologies. These patented systems are critical for optimizing signal strength and reducing interference in mobile networks.

CCA claims its proprietary designs were copied by Ace and sold on a large scale to Jio, thereby infringing on its intellectual property. The plaintiff is seeking ₹1,160 crore in damages.

Court’s Observations

Justice Banerjee relied on earlier court findings and observed that a prima facie case of infringement had already been made in earlier hearings and upheld by the Division Bench and the Supreme Court of India. The court noted that Ace’s financial health had deteriorated, with a 65% drop in market capitalization, and it had no significant presence or assets in India.

These concerns led the court to invoke Section 151 of the Code of Civil Procedure, granting it inherent powers to pass any orders necessary to serve the ends of justice. The ₹290 crore deposit is in addition to the previously secured ₹75 crore, bringing the total security amount to ₹365 crore, reportedly the highest ever in an Indian patent lawsuit.

Patent at the Heart of the Case

CCA’s patent relates to beamforming antenna technology, used in cellular base stations for targeted signal delivery. The company alleges Ace’s antennas replicate these patented designs, offering similar functionality and configurations, thereby infringing on their exclusive rights.

Next Phase of the Case

The Delhi High Court has directed the parties to proceed to the recording of evidence, marking the next critical stage of the trial. The court emphasized that this financial security was crucial to ensure that the plaintiff’s claim does not become unenforceable in the future due to the defendant’s foreign status and lack of assets in India.

This article is based on publicly available information and court documents regarding the Delhi High Court’s proceedings in the patent infringement case between Communication Components Antenna Inc. and Ace Technologies Corp. The details presented are for informational and journalistic purposes only and do not constitute legal advice or opinion. Readers are encouraged to consult official court records or legal experts for more specific interpretations.

Apple Ordered to Pay $110.7M for Patent Infringement

by

Apple Inc. has been ordered to pay $110.7 million in damages after a U.S. federal jury found the tech giant guilty of infringing a wireless communication patent owned by Spanish technology firm TOT Power Control, S.L. The case centered around a key 3G patent used in Apple’s iPhones, iPads, and Apple Watches.

The jury in Delaware federal court determined that Apple had violated U.S. Patent No. 7,532,865, which relates to outer loop power control technology, crucial for improving efficiency in mobile device communication networks. It helps to manage signal strength between a mobile device and network base stations.

What the Verdict Means

The decision follows a lengthy trial in which TOT Power Control alleged that Apple used its patented technology without proper licensing agreements. The awarded amount reflects a running royalty of approximately $0.25 per device that uses the infringing technology, covering a vast range of Apple products operating with 3G capability.

TOT Power Control is a Spain-based intellectual property firm established by inventor and engineer Álvaro López-Medrano. The company focuses on essential wireless communication technologies and has been actively defending its IP rights globally.

Apple responded to the verdict with disappointment, stating it will pursue an appeal. The company has a long history of defending itself in patent infringement suits, particularly around standard-essential patents (SEPs)—those considered fundamental to wireless communication standards like 3G, 4G, and 5G.

Pattern of Patent Disputes for Apple

This ruling adds to a string of legal challenges Apple is currently facing related to SEPs:

In May 2025, a UK court ordered Apple to pay £402 million (approximately $502 million) to Optis Cellular Technology in a separate 4G patent dispute.

In another U.S. case involving Optis, Apple had a $300 million jury verdict overturned after a federal appeals court ruled there were errors in jury instructions.

These cases reflect ongoing tensions between major tech companies and patent holders over FRAND terms—agreements that require essential patent licensing to be fair, reasonable, and non-discriminatory.

Legal and Industry Implications

The ruling reinforces the importance of upholding SEP licensing terms, especially as global tech firms continue to leverage wireless standards in their devices. Analysts suggest the outcome could embolden more patent holders to litigate, particularly in the U.S., where damages can scale significantly.

While $110 million is a modest sum for Apple—whose annual revenues exceed $380 billion—it underscores the financial risks associated with failing to secure or honor licensing deals for standard wireless technologies.

The case also highlights the growing assertiveness of non-U.S. companies, like TOT Power Control, in pursuing patent enforcement across international jurisdictions.

This article is based on publicly available news sources and legal filings related to the Apple vs TOT Power Control patent case. All facts have been verified as of the time of publication. This article is intended for informational purposes only and does not constitute legal or financial advice.

Samsung Faces Legal Battle for Alleged eSIM Patent Violations

by

In a significant development in the world of intellectual property and telecommunications, Network-1 Technologies, Inc. (NYSE: NTIP) has initiated a patent infringement lawsuit against Samsung Electronics Co., Ltd. and Samsung Electronics America, Inc. The suit was filed in the U.S. District Court for the Eastern District of Texas, a jurisdiction known for handling complex patent litigation.

The case revolves around Samsung’s alleged unauthorized use of Network-1’s eSIM and 5G authentication technologies in a wide range of its mobile devices, including smartphones, tablets, and smartwatches.

🔍 Allegations and Patent Details

Network-1 asserts that six U.S. patents from its M2M/IoT (Machine-to-Machine/Internet of Things) portfolio are being violated. These patents—acquired by Network-1 in December 2017—are said to cover core authentication and secure communication technologies used in eSIM-based mobile devices.

The patents in question are expected to remain valid until 2033–2034, placing them well within their enforceable lifespan.

The complaint alleges that Samsung incorporated these patented technologies into its Galaxy series of devices without obtaining a proper license, thereby violating Network-1’s intellectual property rights.

📈 Market Relevance and Timing

The timing of the lawsuit is strategic. According to the Trusted Connectivity Alliance, more than 500 million eSIM-capable devices were shipped globally in 2024 alone—a 56% rise in eSIM profile downloads from the previous year. Samsung is a major player in this fast-growing market.

With the rapid expansion of 5G and eSIM adoption, Network-1’s patented technologies play a critical role in ensuring secure authentication and connectivity—making them highly valuable in today’s mobile device ecosystem.

🧠 About Network-1 Technologies

Network-1 is a well-known intellectual property licensing company that specializes in acquiring and enforcing technology patents. The company does not manufacture products but focuses on monetizing its IP assets through licensing and litigation.

Their M2M/IoT patent portfolio includes:

41 U.S. patents

15 international patents

25 pending applications globally

⚖️ Legal Strategy and Implications

Filing in the Eastern District of Texas—a patent-holder-friendly court—could give Network-1 a strategic advantage. Samsung, on the other hand, is expected to vigorously defend its position, potentially challenging the validity, enforceability, or scope of the patents.

Legal experts suggest that if Network-1 prevails, it could result in:

A licensing agreement worth millions

Monetary damages

A possible injunction against the sale of infringing devices

Given the global scale of Samsung’s product distribution, the outcome of this case could have far-reaching consequences for both parties.

🔮 What’s Next?

Both parties are likely to engage in extensive pre-trial activities, including evidence discovery and expert testimony. The tech industry will be closely watching the case, which could reshape licensing norms in the high-growth sectors of 5G, IoT, and mobile security.

Delhi High Court Blocks Unauthorized Streaming of India Tour 2025

by

In a landmark ruling, the Delhi High Court has granted a Dynamic+ injunction in favor of JioCinema and Disney+ Hotstar, blocking unauthorized streaming of the highly anticipated India Tour of England 2025.

Court Recognizes Clear Copyright Violation

Justice Sanjeev Narula of the Delhi High Court acknowledged that unauthorized streaming platforms were blatantly infringing copyright by broadcasting the live cricket series without permission. The court classified this as a “clear example of copyright infringement.”

The rights for the digital broadcast of the series are held exclusively by JioCinema and Disney+ Hotstar, through Viacom18 and Star India respectively.

What Is a Dynamic+ Injunction?

The Dynamic+ injunction allows rights holders to immediately block new rogue domains that illegally stream the matches, without needing to approach the court repeatedly. This proactive measure ensures that pirates can’t bypass bans by simply changing URLs or creating mirror sites.

The court emphasized that such swift actions are essential in dealing with the “menace of online piracy,” particularly during live sports broadcasts, where real-time viewership is commercially critical.

45 Rogue Websites Already Blocked

The order has already resulted in the blocking of over 45 pirate websites. Internet Service Providers (ISPs) have been directed to disable access to these domains.

Industry Applauds Ruling

The decision has been welcomed by broadcasters and content creators, who have long demanded stricter enforcement mechanisms against digital piracy.

A spokesperson from Viacom18 said, “This ruling protects our significant investments in sports content and sends a strong message to digital pirates.”

This article is based on publicly available information and legal filings. It does not constitute legal advice. All names, trademarks, and brands mentioned belong to their respective owners

Court Rules in Favor of WEE POWER Trademark Over Ferrari

by

In a significant legal decision, the Kuala Lumpur High Court has ruled in favor of Sunrise-Mark Sdn Bhd, a Malaysian company that produces the energy drink WEE POWER, in a trademark dispute brought by luxury Italian carmaker Ferrari SpA.

Ferrari alleged that the WEE POWER logo, which features two rearing horses on either side of a prominent “W”, bore too close a resemblance to Ferrari’s iconic single rearing horse emblem, potentially misleading consumers and damaging Ferrari’s brand identity. However, the court dismissed these claims, stating that the trademarks are distinct in design, context, and usage.

Case Overview

The dispute arose when Sunrise-Mark applied to register the WEE POWER trademark in Malaysia. Ferrari objected, arguing that the drink’s branding, particularly the horse imagery, could cause brand confusion and infringe upon Ferrari’s intellectual property.

The court, however, found the argument to be without sufficient basis. Presiding judge Justice Wong Kian Kheong highlighted that while both logos contain horse figures, their visual representation and overall branding are clearly distinguishable.

Court’s Findings

In the detailed judgment, the court noted several key differences:

Logo Structure: Ferrari’s emblem is a solitary horse standing on its hind legs, a symbol tightly associated with its automotive legacy. In contrast, WEE POWER’s mark features two horses, each facing inward with a stylized “W” at the center and the words “WEE POWER” below.

Sector Disparity: Ferrari is a luxury automobile brand, while Sunrise-Mark produces consumer beverages. The judge stated that it is unlikely any reasonable consumer would associate an energy drink with a supercar manufacturer.

Meaning of “WEE”: The name “WEE” was accepted by the court as being derived from the name of the company’s founder, Wee Juan Chien, rather than an attempt to imitate or draw attention through the use of the English word.

Due to these factors, the court ruled there was no risk of public confusion nor evidence of any intention by Sunrise-Mark to exploit Ferrari’s brand image.

Sunrise-Mark Can Proceed with Trademark

As a result of the decision, Sunrise-Mark is now legally permitted to register and use the WEE POWER logo in Malaysia. The court also ordered Ferrari to bear the legal costs of the proceedings, solidifying the judgment in favor of the Malaysian company.

Company Reactions

Sunrise-Mark issued a statement celebrating the decision as a win for local entrepreneurs and fair competition. The company emphasized that its branding was designed independently and intended to reflect its identity, not to mimic or capitalize on any global trademarks.

Ferrari has not yet released an official statement regarding the ruling or whether it plans to appeal.

Implications of the Ruling

This case highlights the boundaries of trademark protection, especially when large international brands attempt to challenge local firms in unrelated sectors. The decision reinforces that context, industry, and branding clarity are critical in determining trademark conflicts.

This article is for informational purposes only and is based on publicly available reports as of June 2025. It does not offer legal advice. All brand names and logos mentioned are the property of their respective owners.

Japan Grants Patent for Non-Invasive Endometriosis Test

by

Proteomics International Laboratories Ltd (ASX: PIQ), a global leader in predictive diagnostics, has announced that it has been granted its first patent in Japan for Pro marker Endo—a world-first, non-invasive blood test developed to diagnose endometriosis. This strategic patent grant represents a major milestone in the company’s global intellectual property (IP) rollout and sets the stage for accelerated commercialization across key markets.

Groundbreaking Diagnostic Solution

Endometriosis is a chronic inflammatory condition affecting roughly 1 in 9 women of reproductive age, characterized by the growth of tissue similar to the uterine lining outside the uterus. It causes severe pelvic pain, infertility, and impacts mental and physical well-being. Current diagnostic methods—mainly laparoscopic surgery—are invasive, expensive, and result in diagnostic delays of 7 to 10 years on average.

PromarkerEndo offers a revolutionary alternative. Using a simple blood sample, the test applies a biomarker-based algorithm to detect the presence of endometriosis and deliver results in the form of a “traffic light” system:

Green: Low likelihood of endometriosis

Amber: Moderate likelihood

Red: High likelihood

This intuitive format provides clinicians with actionable insights, greatly improving early-stage detection and treatment planning.

Strong Clinical Results

The PromarkerEndo test has demonstrated outstanding clinical performance in both research and real-world settings. Results from a landmark clinical study involving 704 participants—recently presented at the 16th World Congress on Endometriosis (May 2025)—highlighted the test’s exceptional diagnostic accuracy. The area under the curve (AUC), a measure of diagnostic performance, ranged from 0.89 to 0.94, particularly excelling in early-stage (I-II) detection.

These outcomes surpass many traditional diagnostic approaches and emphasize the test’s utility as a first-line screening tool in both primary and specialist care.

Strategic Importance of the Japanese Patent

The patent granted by the Japan Patent Office significantly enhances Proteomics International’s global IP portfolio. Japan, with a population of over 125 million and an advanced healthcare system, represents a high-value market for women’s health diagnostics. The new patent strengthens the company’s freedom to operate in Asia and supports upcoming commercial launches.

Proteomics International now holds patents or patent applications for PromarkerEndo in Australia, China, Europe, and the United States, with the Japanese grant adding further momentum to its global rollout.

Managing Director Dr. Richard Lipscombe commented:

“The Japanese patent is a critical milestone in protecting our proprietary technology in one of the world’s most sophisticated healthcare markets. It reinforces the strength of our innovation and supports our mission to bring non-invasive, accessible diagnostics to women suffering from endometriosis worldwide.”

Path to Commercialization

Proteomics International is actively working towards the initial commercial launch of PromarkerEndo in Australia by Q3 2025, with other markets such as Japan, the EU, and the U.S. expected to follow. The company is in discussions with diagnostic partners and health providers to integrate PromarkerEndo into standard clinical pathways.

The potential market for the test is vast. With endometriosis affecting over 190 million women globally, and with growing public and clinical awareness, demand for improved diagnostics is surging.

Broader Implications

Beyond offering a non-invasive alternative to laparoscopy, PromarkerEndo has the potential to reshape how healthcare systems approach chronic women’s health conditions. By enabling earlier diagnosis:

Patient outcomes can improve dramatically

Healthcare costs associated with delayed diagnosis and invasive procedures may be reduced

Physicians gain a powerful tool for faster triage and referral

Additionally, this development aligns with global policy shifts focused on addressing historical gaps in women’s health research and diagnostics.

Conclusion

The Japanese patent marks a crucial step forward for Proteomics International and its pioneering PromarkerEndo test. With clinical validation, global IP protection, and a clear path to market, the company is well-positioned to transform endometriosis diagnosis—bringing hope to millions of women who have long faced delays, misdiagnosis, and inadequate care

🔖 Disclaimer:

This article is based on publicly available information provided by Proteomics International Laboratories and related sources.